C. Von Hunolstein et al., Virulence properties of type VII Streptococcus agalactiae (group B streptococci) and immunochemical analysis of capsular type polysaccharide, J MED MICRO, 48(11), 1999, pp. 983-990
Strains of a new polysaccharide type of group B streptococci (GBS), type VI
I, have been isolated from human carriers and invasive infections. Some of
these strains bear the protein antigen c or R, as do other GBS serotypes. T
he capsular type polysaccharide is sialylated and this residue is involved
in the immunodeterminant structure. All type VII strains examined were viru
lent in CD-1 mice; the LD50 after intraperitoneal (i.p.) challenge was 4.57
(SD 0.12) x 10(7) cfu for the :reference strain and 5.49 (SD 1.5) x 10(7)
cfu for clinical isolates. A particular feature of this serotype was the ab
ility to induce septic arthritis not only when injected intravenously (i.v.
), but also when injected i.p. Rabbit antiserum against the capsular type V
II polysaccharide exhibited opsonic activity in a phagocytosis assay and pr
otective activity against infection.